Human hallucinogenic drug research in the United States: a present-day case history and review of the process.
R J Strassman
Journal of Psychoactive Drugs 1991 DOI: 10.1080/02791072.1991.10472572 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Interventions | N N-dimethyltryptamine (DMT) |
| Keywords | Humans Hallucinogens Legislation, drug United states |
| Key points | Argues that although regulatory hurdles have discouraged human hallucinogen research, such work remains possible, as shown by the author's successful application for federal permission to administer DMT to humans; further progress requires persistent, collaborative effort with the relevant oversight institutions. |
Abstract
Legitimate human research with hallucinogenic drugs, although of great theoretical and practical interest, involves daunting regulatory hurdles that have discouraged investigators from attempting such work. Using the example of the author's own application for and receipt of federal permission to administer N,N-dimethyltryptamine (DMT) to humans, this article reviews the application process, obstacles and their solutions, and the local and federal issues involved. Further human research with hallucinogens is possible if a persistent and collaborative effort is made with the relevant institutions that oversee the performance of this type of research.
Citations in the library
Cited by 32
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Long-term effects of psychedelic drugs: A systematic review Neuroscience & Biobehavioral Reviews March 16, 2020
- Human psychopharmacology of N,N-dimethyltryptamine Behavioural Brain Research December 1, 1995
- Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature BMC Psychiatry July 31, 2018
- The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion Journal of Psychedelic Studies July 1, 2019
and 27 more in the library
Cites 5
- ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE The Journal of Nervous and Mental Disease October 1, 1984
- The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine American Journal of Psychiatry February 1, 1976
- Dreams, Hallucinogenic Drug States, and Schizophrenia: A Psychological and Biological Comparison Schizophrenia Bulletin 1983
- Localization of serotonin 5‐HT2 receptors in living human brain by positron emission tomography using N1‐([11C]‐methyl)‐2‐BR‐LSD Synapse 1987
- LSD: Personality and Experience British Journal of Addiction to Alcohol & Other Drugs December 1, 1973